Literature DB >> 2423610

Effect of an inhibitor of DNA methylation on T cells. I. 5-Azacytidine induces T4 expression on T8+ T cells.

B Richardson, L Kahn, E J Lovett, J Hudson.   

Abstract

Maturing thymocytes express a series of cell surface glycoproteins which can be identified by monoclonal antibodies. The stage II or common thymocyte expresses the phenotype T4+T8+T6+T3-. In response to unknown signals, but presumably involving interactions with products of the major histocompatibility complex, the thymocyte suppresses either the T8 or T4 gene, becoming committed to the T4+T8- or T4-T8+ phenotype. With maturation, the thymocyte also becomes T6-T3+. To study whether DNA methylation may be involved in regulating expression of these determinants in mature T cells, we treated cloned interleukin 2-dependent T8- and T4-bearing T cells with 5-azacytidine (5-azaC), a nucleoside analog which inhibits methylation of newly synthesized DNA. In this report, we show that T8+ T cells treated with 5-azaC express the phenotype T8+T4+T6-T3+. Treatment of the same cells with hydroxyurea, an inhibitor of DNA synthesis, failed to induce T4 on T8+ cells. These results suggest that expression of the T4 gene may be suppressed by DNA methylation in mature T8+ cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423610

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  The therapeutic potential of epigenetics in autoimmune diseases.

Authors:  Maria De Santis; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  Correlation between miR-126 expression and DNA hypomethylation of CD4+ T cells in rheumatoid arthritis patients.

Authors:  Ge Yang; Daoquan Wu; Guang Zeng; Ou Jiang; Pingzong Yuan; Shenjie Huang; Jing Zhu; Jie Tian; Yaguang Weng; Zhihua Rao
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis.

Authors:  L Flamand; R W Crowley; P Lusso; S Colombini-Hatch; D M Margolis; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

4.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.

Authors:  M Thurnher; S Rusconi; E G Berger
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Coexpression of CD4 and CD8 on peripheral blood T cells and lamina propria T cells in inflammatory bowel disease by two colour immunofluorescence and flow cytometric analysis.

Authors:  M Senju; K C Wu; Y R Mahida; D P Jewell
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

7.  CD4 promoter transactivation by human herpesvirus 6.

Authors:  L Flamand; F Romerio; M S Reitz; R C Gallo
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 8.  Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications.

Authors:  Adam Cribbs; Marc Feldmann; Udo Oppermann
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

9.  Hydralazine target: from blood vessels to the epigenome.

Authors:  Claudia Arce; Blanca Segura-Pacheco; Enrique Perez-Cardenas; Lucia Taja-Chayeb; Myrna Candelaria; Alfonso Dueñnas-Gonzalez
Journal:  J Transl Med       Date:  2006-02-28       Impact factor: 5.531

10.  Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.

Authors:  Claudio Carini; Ewan Hunter; Aroul S Ramadass; Jayne Green; Alexandre Akoulitchev; Iain B McInnes; Carl S Goodyear
Journal:  J Transl Med       Date:  2018-01-29       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.